Tim Daniel Rose

Mr. Tim Daniel Rose

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SSSepideh Sadegh
Sepideh Sadegh
JMJulian Matschinske
Julian Matschinske
DBDavid B. Blumenthal
David B. Blumenthal
GGGihanna Galindez
Gihanna Galindez
TKTim Kacprowski
Tim Kacprowski
Jan BaumbachJan Baumbach
Jan Baumbach
Coronavirus Disease-2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Various studies exist about the molecular mechanisms of viral infection. However, such information is spread across many publications and it is very time-consuming to integrate, and exploit. We develop CoVex, an interactive online platform for SARS-CoV-2 host interactome exploration and drug (target) identification. CoVex integrates virus-human protein interactions, human protein-protein interactions, and drug-target interactions. It allows visual exploration of the virus-host interactome and implements systems medicine algorithms for network-based prediction of drug candidates. Thus, CoVex is a resource to understand molecular mechanisms of pathogenicity and to prioritize candidate therapeutics. We investigate recent hypotheses on a systems biology level to explore mechanistic virus life cycle drivers, and to extract drug repurposing candidates. CoVex renders COVID-19 drug research systems-medicine-ready by giving the scientific community direct access to network medicine algorithms. It is available at https://exbio.wzw.tum.de/covex/.

14 January 2021 in Nature Computational Science
Verified
Journal Article
Closed access
PDF file
GGGihanna Galindez
Gihanna Galindez
JMJulian Matschinske
Julian Matschinske
TRTim Daniel Rose
Tim Daniel Rose
SSSepideh Sadegh
Sepideh Sadegh
MSMarisol Salgado-Albarrán
Marisol Salgado-Albarrán
Josch K. PaulingJosch K. Pauling
Josch K. Pauling

2 January 2023 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
TRTim Daniel Rose
Tim Daniel Rose
NKNikolai Koehler
Nikolai Koehler
LFLisa Falk
Lisa Falk
LKLucie Klischat
Lucie Klischat
OLOlga E Lazareva
Olga E Lazareva
Josch K. PaulingJosch K. Pauling
Josch K. Pauling
Lipidomics is of growing importance for clinical and biomedical research due to many associations between lipid metabolism and diseases. The discovery of these associations is facilitated by improved lipid identification and quantification. Sophisticated computational methods are advantageous for interpreting such large-scale data for understanding metabolic processes and their underlying (patho)mechanisms. To generate hypothesis about these mechanisms, the combination of metabolic networks and graph algorithms is a powerful option to pinpoint molecular disease drivers and their interactions. Here we present lipid network explorer (LINEX$^2$), a lipid network analysis framework that fuels biological interpretation of alterations in lipid compositions. By integrating lipid-metabolic reactions from public databases, we generate dataset-specific lipid interaction networks. To aid interpretation of these networks, we present an enrichment graph algorithm that infers changes in enzymatic activity in the context of their multispecificity from lipidomics data. Our inference method successfully recovered the MBOAT7 enzyme from knock-out data. Furthermore, we mechanistically interpret lipidomic alterations of adipocytes in obesity by leveraging network enrichment and lipid moieties. We address the general lack of lipidomics data mining options to elucidate potential disease mechanisms and make lipidomics more clinically relevant.

28 July 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
NKNikolai Koehler
Nikolai Koehler
TRTim Daniel Rose
Tim Daniel Rose
LFLisa Falk
Lisa Falk
Josch K. PaulingJosch K. Pauling
Josch K. Pauling
Lipids play an important role in biological systems and have the potential to serve as biomarkers in medical applications. Advances in lipidomics allow identification of hundreds of lipid species from biological samples. However, a systems biological analysis of the lipidome, by incorporating pathway information remains challenging, leaving lipidomics behind compared to other omics disciplines. An especially uncharted territory is the integration of statistical and network-based approaches for studying global lipidome changes. Here we developed the Lipid Network Explorer (LINEX), a web-tool addressing this gap by providing a way to visualize and analyze functional lipid metabolic networks. It utilizes metabolic rules to match biochemically connected lipids on a species level and combine it with a statistical correlation and testing analysis. Researchers can customize the biochemical rules considered, to their tissue or organism specific analysis and easily share them. We demonstrate the benefits of combining network-based analyses with statistics using publicly available lipidomics data sets. LINEX facilitates a biochemical knowledge-based data analysis for lipidomics. It is availableas a web-application and as a publicly available docker container.

17 August 2011 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
HPH. Pilge
H. Pilge
JSJ. Spang
J. Spang
TRTim Daniel Rose
Tim Daniel Rose
HWH. Wolter
H. Wolter
KWK. Woertler
K. Woertler
AIA. B. Imhoff
A. B. Imhoff

11 April 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
TRTim Daniel Rose
Tim Daniel Rose
TBThibault Bechtler
Thibault Bechtler
OCOctavia Andreea Ciora
Octavia Andreea Ciora
KLKim Anh Lilian Le
Kim Anh Lilian Le
FMFlorian Molnar
Florian Molnar
Josch K. PaulingJosch K. Pauling
Josch K. Pauling
Significance: Molecular patient stratification and disease subtyping are ongoing and high-impact problems that rely on the identification of characteristic molecular signatures. Current computational methods show high sensitivity to custom parameterization, which leads to inconsistent performance on different molecular data. Our new method, MoSBi (molecular signature identification using biclustering), 1) enables so far unmatched high performance for stratification and subtyping across datasets of various different biomolecules, 2) provides a scalable solution for visualizing the results and their correspondence to clinical factors, and 3) has immediate practical relevance through its automatic workflow where individual selection, parameterization, screening, and visualization of biclustering algorithms is not required. MoSBi is a major step forward with a high impact for clinical and wet-lab researchers.